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AbstrAct
We describe a patient affected by cushing’s disease due to the presence of double pituitary ad-
enomas, one located within the anterior pituitary and the other in the infundibulum associated 
with a remnant of rakthe’s pouch. cure was achieved only after the infundibulum lesion was 
surgically removed. cAsE rEPOrt: A 38-year-old female presented with unexplained weight 
gain, hirsutism, amenorrhea, asthenia, recurrent cutaneous micotic infections and alopecia. 
Hormonal studies indicated cushing’s disease and MrI showed an enlarged pituitary gland 
with a marked and homogeneous enhancement after injection of gadolinium and an enlarged 
infundibulum with a maximum diameter of 8 mm. As a venous sampling of the inferior pet-
rosal sinus after 10 μg iv desmopressin stimulation revealed a central to peripheral ActH 
ratio consistent with a pituitary ActH-secreting tumor, transphenoidal explorative surgery 
was performed and a 4-mm pituitary adenoma immunopositive for ActH was disclosed and 
removed. since postoperative hormonal evaluation showed persistent hypercortisolism, con-
firmed by dynamic tests, the patient again underwent surgery by transcranial access and the 
infundibulum mass was removed. Histology and immunochemistry were consistent with an 
ActH-secreting adenoma. A few months after the second operation, cushingoid features were 
significantly reverted and symptoms improved. cONcLUsION: Although cushing’s patients 
bearing multiple adenomas have already been documented, the presence of two adenomas both 
immunohistochemically positive for ActH is a very rare cause of cushing’s disease and this 
is the first report of a case of double ActH-producing adenomas, one located in the pituitary 
gland and one attached to the stalk.
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IntroductIon
Multiple pituitary adenomas are defined as simul-
taneous, morphologically or immunocytologically, 
distinct tumors1 and are classified as contiguous and 
clearly separated double tumors. These tumors are 
rarely detected among surgical specimens (0.004-
0.01%), the most frequent clinical manifestation in the 
reported patients being acromegaly.2 The diagnosis 
of double pituitary adenomas is, in most cases, based 
on histopathologic examination, since preoperative 
evaluation and MRI are able to identify multiple 
adenomas in only a few cases. These adenomas can 
belong to the same or to different hormone groups, 
making different combinations possible: ACTH-PRL 
secreting tumors appear to be the most common, 
followed by GH-non functioning adenomas and GH-
PRL adenomas.2 Herein we describe, to the best of 
our knowledge, the first case in the recent literature 
of a middle-aged woman with Cushing’s disease due 
to double adenomas, one located within the anterior 
pituitary and the other in the infundibulum. 
case presentatIon 
A 38-year-old woman was referred to our Endo-
crinology Unit as she had shown over the last three 
years progressive unexplained weight gain (>25 Kg 
bw) and hirsutism. Secondary amenorrhea had been 
present for six months. A polycystic ovary syndrome 
had been previously diagnosed and she was enrolled 
in a weight reduction program, without, however, 
any improvement. Moreover, one year before she 
developed typical hypercortisolemic clinical features 
including weight gain, depression, alopecia, profound 
asthenia, recurrent cutaneous micotic infections. She 
denied current use of alcohol. She did not suffer 
from other multiple endocrine neoplasia (MEN1) 
or Carney complex clinical manifestations. 
On physical examination, vital signs were normal, 
weight was 90 kg and height was 169 cm (BMI 31.5 
kg/m2). Other clinical signs, e.g. moon face with mild 
plethora, truncal obesity, alopecia, thin skin with many 
bruises and abdominal striae, suggested the presence 
of Cushing’s syndrome. 
Her morning plasma ACTH and serum cortisol 
levels were 40-70 pg/ml and 497-821 nmol/L, respec-
tively. Both overnight low dose (1 mg) dexamethasone 
(DXM) and low dose (2 mg for 2 days) DXM test 
showed an inadequate suppression of her serum 
cortisol (390 nmol/L/dl and 355 nmol/L, respectively; 
normal suppression <50 nmol/L). Hypercortisolism 
was further confirmed by elevated urinary free cortisol 
(407-960 nmol/24h; normal range 35-275 nmol/24h). 
High dose dexamethasone suppression test (8+8 
mg for 2 days) revealed suppression of both serum 
cortisol (from 868 to 108 nmol/L) and UFC (urinal 
free cortisol) levels (from 960 to 59 nmol/24h). A 
corticotropin releasing hormone test (CRH; 1 mcg/
kg bw) revealed greatly increased levels of both cor-
tisol and ACTH (by +76% and +92%, respectively, 
over baseline). 
A positive response to ACTH (from 43 to 112 
pg/ml, +160%) and cortisol levels (from 507 to 757 
nmol/L, +49%) was found also after desmopressin 
stimulation (DDAVP; 10 mcg i.v.).
Magnetic resonance imaging (MRI) of the hy-
pothalamic-pituitary region revealed an enlarged 
pituitary gland with a marked and homogeneous 
enhancement after gadolinium i.v. Indeed, the infun-
dibulum was enlarged with a maximum diameter of 
8 mm and impinged on the optic chiasm (Figure 1). 
Visual field evaluation revealed a minimal peripheral 
loss. As MRI did not identify a typical intrapituitary 
tumor, the patient underwent bilateral inferior petrosal 
sinus sampling during desmopressin stimulation. The 
central to peripheral ratio of ACTH was 6.17 on the 
Figure 1. On the left, coronal T1-weighted, contrast-enhanced 
MR imaging showing a rounded mass located at the level of the 
pituitary stalk, over the pituitary gland, that appears intact; on 
the right, sagittal T1-weighted, contrast-enhanced MR imaging 
confirming the presence of a round mass located at the level of 
the pituitary stalk, over the pituitary gland, which in this plane 
seems enlarged in volume.
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left side after desmopressin, suggesting a possible 
corticotropinoma on that side. No pituitary hormones 
deficiencies were present.
The patient underwent transsphenoidal surgery 
to search for an intrapituitary microadenoma. After 
careful exploration of the pituitary gland, a grey 
soft tumor was identified and completely removed. 
The surgical specimen consisted of 4 mm of tissue 
and microscopically showed fragments of pituitary 
adenoma. The adenoma cells were immunoreactive 
for ACTH (Figure 2A) and immunonegative for LH, 
FSH, GH, PRL and chromogranin A. 
Despite these findings, postoperative hormonal 
evaluation showed persistent hypercortisolism.
Thereafter, based on the preoperative MRI find-
ings, we strongly suspected that the lesion observed 
in the enlarged infundibulum might be a further 
source of ACTH secretion. Thus, one month later 
the patient underwent a second operation in order 
to remove the infundibulum lesion by transcranic 
access. Histological examination revealed remnants 
of Rakthe’s pouch associated with a pituitary mi-
croadenoma. Immunohistochemical staining again 
demonstrated a positive reaction for ACTH (Figure 
2B) and negative ones for LH, FSH, PRL, GH and 
chromogranin A. 
Soon after the operation, ACTH and cortisol levels 
decreased to 4-7 pg/ml and 11-57 nmol/L, respec-
tively, (Table 1). In the subsequent days, weakness, 
fatigue, hypotension and skin pallor, indicative of 
a hypoadrenal condition, progressively ensued. As 
signs of central hypopituitarism (LH <0.1 mIU/ml, 
FSH <0.1 mIU/ml, TSH 0.01 µUI/ml) appeared, 
hormonal replacement therapy was initiated, includ-
ing cortisone acetate, l-thyroxine, desmopressin and 
estro-progestinic therapy. 
dIscussIon
We herein describe a patient with Cushing’s dis-
ease due to the presence of two ACTH-secreting 
adenomas, one located within the anterior pituitary 
and the other in the infundibulum. 
Very recently, an incidence of 2.6% of double 
pituitary adenomas in an unselected surgical series 
of 117 patients undergoing surgery for pituitary ad-
enoma was reported.3 Previously, Kontogeorgos et al4 
table 1. Serum cortisol and plasma ACTH levels before and after surgery
before surgery
After 1st surgical 
operation
After 2nd surgical 
operation Normal range
Cortisol (nmol/l)
Basal 503 420 <28 140-700
After DXM 1mg 390 - <28 <50
ACTH (pg/ ml) 43 71 7.7 10-90
Figure 2. A: Intrapituitary mi-
croadenoma: adenomatous 
cells with positive immuno-
chemistry for ACTH (4×); 
b: Adenoma attached to the 
stalk: adenomatous cells with 
positive immunostaining for 
ACTH (10×).
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Some authors suggested that one adenoma can 
induce the formation of another, mainly in cases of 
GH-secreting adenomas which release factors that may 
promote the proliferation of a secondary adenoma.1,7 
Anyway, the role of pituitary and extrapituitary factors 
in inducing clonal expansion of genetically altered cells 
would be considered in the occurrence of multiple 
adenomas. In our patient, the existence of multicentric 
adenomas would be more plausible because the co-
existing adenomas were completely separated from 
each other. In this context, the origin of the adenoma 
located within the stalk may be explained as a conse-
quence of corticotroph basophilic invasion from the 
residual intermediate lobe into the posterior lobe. 
Starting from young adulthood, some corticotrophs 
in the zona intermedia proliferate into the posterior 
pituitary lobe and become more prominent with ag-
ing. A basophilic invasion has also been implicated 
as the possible origin of the extremely rare pituitary 
ACTH secreting adenomas arising from within the 
posterior lobe.21,22 
A poor surgical outcome has been reported in 
patients with double adenoma in whom the noncausa-
tive lesion was removed during the first operation. In 
the present case, hormonal data soon after surgery 
indicated the persistence of hypercortisolism and led 
the neurosurgeon to remove the lesion suspected at 
preoperative MR imaging of an enlarged infundibu-
lum. The early occurrence of hypoadrenalism in the 
postoperative days indicated that a second cortico-
tropinoma was resected: in fact, both tumors stained 
for ACTH on immunohistochemistry. 
It is noteworthy in this regard that ACTH-secreting 
adenomas originating in, or extending into, the pi-
tuitary stalk have been previously observed.23 These 
observations, together with the present case of double 
ACTH-producing adenomas, one in the anterior pi-
tuitary and the other attached to the pituitary stalk, 
once again emphasize that double ACTH-secreting 
adenomas may occur and that they need careful 
surgical management to recognize multiple lesions 
and to achieve a clinical resolution of Cushing’s 
disease. On the other hand, the normalization of 
hormone hypersecretion cannot be achieved when 
the co-existing hypersecreting tumor is missed during 
surgery. In our case, the preoperative MR imaging 
of an enlarged infundibulum enabled us to discover, 
showed that 8.9% of adenomas found at autopsy were 
multiple and, overall, 0.9% of autopsies detected the 
presence of multiple pituitary adenomas. It has also 
been emphasized that these tumors may occasionally 
co-exist with other brain tumors1,5-9 and that they may 
be distinguished as contiguous and clearly separated 
double tumors. 
In autopsy specimens of double adenomas, prol-
actin was the most common immunoreactive secreted 
hormone,4,10 while most of the double adenomas in 
surgical series were a combination of GH-secreting 
and clinically non-functioning adenomas:1,7,11-13 in fact, 
acromegaly has been shown to be the most frequent 
clinical feature in surgical series of double pituitary 
adenomas.1,5,7 Patients with somatotropinoma plus 
gonadotroph adenoma and cases of prolactinoma as-
sociated with GH-secreting adenoma have also been 
described.1,7,14 It is of note that multiple (as many as 
three) intrapituitary non-functioning adenomas have 
also been described.15
By contrast, immunostaining for adrenocortico-
tropic hormone in surgically resected double adeno-
mas have rarely been described and these corticotroph 
adenomas were either “silent” or clinically active. In 
any case, isolated cases of Cushing’s disease patients 
with double4,6,7,16 and also triple17 adenomas have been 
documented. 
As far as double adenomas are concerned, ACTH-
secreting pituitary adenomas have been described 
together with silent prolactinomas in two cases,16,17 
with active PRL-secreting adenomas in four cases,1,2,6,16 
with a somatotropinoma associated with acromegaly in 
one patient6 and with a silent FSH-secreting adenoma 
in another one.18 Only one case of double pituitary 
adenomas ACTH-secreting has been reported recently 
in the literature19.
Owing to the rare occurrence of double pituitary 
adenomas, their pathogenesis is not known, but sev-
eral possible mechanisms may be considered. One is 
a multicentric origin in the same pituitary, i.e. real 
double adenoma. The cause of multicentric adenomas 
might include incidental occurrence, promotion of the 
second adenoma growth through autocrine/paracrine 
pathways and a common origin. For example, studies on 
transgenic mice reported that several pituitary-driven 
growth factors can induce pituitary hyperplasia.20
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after the surgical failure, a second ACTH-secreting 
adenoma associated with a remnant of Rathke’s 
pouch. To our knowledge, this is the first case of 
double ACTH-producing adenomas, one located in 
the anterior pituitary and the other attached to the 
pituitary stalk, reported in the literature.
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